Abstract
Men on active surveillance (AS), with prostate cancer, are very interested in dietary strategies that could improve their symptoms and help prevent progression of their disease. In this real-world trial involving 208 men, intake of phytochemical-rich food capsules helped slow prostate-specific antigen (PSA) progression significantly, and improved urinary symptoms and erectile function. What was novel about this study was that men randomised to take an additional blend of five Lactobacillus probiotics had a further three-fold slowing of PSA progression as well as reduction of inflammation. Currently, nearly 50% of men opt out of AS within 5 yr. If confirmed with further follow-up, these dietary interventions, alongside other lifestyle manoeuvres, could reassure men to remain on AS, and hence avoid the risks of radiotherapy, hormones, or surgery.
| Original language | English |
|---|---|
| Pages (from-to) | 193-198 |
| Number of pages | 6 |
| Journal | European Urology Oncology |
| Volume | 9 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 27 Oct 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Probiotics
- prostate cancer
- Prostatic Neoplasms/diet therapy
- Probiotics/therapeutic use
- Double-Blind Method
- Humans
- Middle Aged
- Male
- Aged
- Phytochemicals/administration & dosage
- Disease Progression
- Lactobacillus
ASJC Scopus subject areas
- Surgery
- Oncology
- Radiology, Nuclear Medicine and Imaging
- Urology
Fingerprint
Dive into the research topics of 'Increasing phytochemical-rich foods and Lactobacillus probiotics in men with low-risk prostate cancer: a randomised, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver